21 drugs! Anti cancer drugs special record procurement publicity, Hengrui, Qilu, Zhengda Tianqing

On March 14, Zhejiang Province issued the announcement on the evaluation results of special record procurement of anticancer drugs According to the requirements of work plan for special centralized procurement of anticancer drugs in Zhejiang Province and administrative measures for drug record and procurement in Zhejiang Province The products to be included in the temporary record procurement catalogue after evaluation and the products to be included in the record procurement catalogue according to the rules (only the imported high-quality products win the bid or have been included in the record procurement catalogue, and the domestic products with the same product specification can be included in the record procurement catalogue after being publicized) shall be publicized (see Appendix 1 and 2 for details) Publicity time: from March 14 to March 20, 2019 (7 days) There are 11 product specifications to be included in the temporary record procurement catalogue, involving Pfizer, Hengrui, Qilu, Shuanglu and other enterprise products According to the rules, the products proposed to be included in the catalogue of record procurement are totally 10 product regulations, involving the products of Haizheng, Zhengda Tianqing and other enterprises.